XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.3
ORGANIZATION AND NATURE OF BUSINESS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Financial assets $ 64,519,982           $ 64,519,982   $ 66,014,811
Net loss (2,182,534) $ (2,590,711) $ (1,866,690) $ (3,349,204) $ (981,530) $ (459,863) (6,639,935) $ (4,790,597)  
CANA Pharmaceutical Laboratories, S.A. ("Cana") [Member]                  
Cash             5,331,120    
Fair value of common stock issued       $ 138,667     138,667    
Fair value of total consideration transferred             5,469,787    
Financial assets 1,796,911           1,796,911    
Inventory 297,340           297,340    
Property, plant and equipment 7,488,818           7,488,818    
Identifiable intangible assets 562,200           562,200    
Financial liabilities (3,235,233)           (3,235,233)    
Total identifiable net assets 6,910,036           6,910,036    
Bargain purchase gain $ 1,440,249           1,440,249    
Revenue             549,567    
Net loss             $ (1,674,785)